BioCentury
ARTICLE | Management Tracks

Blackstone draws on four senior advisers’ diverse experiences as deal range continues to expand

Brandicourt, Ishrak, Nader, Popovits bring expertise across fields

May 24, 2021 11:02 AM UTC

Four senior advisers will guide Blackstone Life Sciences’ management team as it continues to execute on a strategy that has evolved beyond the firm’s original goals built around risk-sharing deals.

The group includes former Sanofi (Euronext:SAN; NASDAQ:SNY) CEO Olivier Brandicourt; ex-Medtronic plc (NYSE:MDT) Chairman and CEO Omar Ishrak; François Nader, a former CEO of NPS Pharmaceuticals Inc., now part of Takeda Pharmaceutical Co. Ltd. (Tokyo:4502); and Kim Popovits, a former chairman and CEO of cancer diagnostics company Genomic Health Inc., which Exact Sciences Corp. (NASDAQ:EXAS) acquired...

BCIQ Company Profiles

Blackstone Life Sciences